Micro- and Nanoparticles for Treating Cardiovascular Disease

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Cardiovascular Research

Background:

• Cardiovascular diseases, such as myocardial infarction (MI) and peripheral artery disease (PAD), affect millions, with current treatments inadequately restoring blood flow or repairing ischemic damage.
• Vessel occlusion leads to ischemic injury in the heart and skeletal muscle, necessitating advanced therapeutic strategies.

Purpose of the Study:

• To review existing particle-based therapies for treating myocardial infarction (MI) and peripheral artery disease (PAD).
• To explore the potential of micro- and nano-particles as delivery vehicles for therapeutic agents in cardiovascular disease treatment.

Main Methods:

• Review of current literature on particle-based therapies for MI and PAD.
• Analysis of micro- and nano-particle formulations and their delivery mechanisms (direct injection vs. intravenous).

Main Results:

• Micro- and nano-particles are being developed as delivery systems for growth factors, enzymes, and small molecules.
• These particles offer sustained therapeutic stimulus at injury sites.
• Particle formulations allow for targeted delivery via direct injection or accumulation after intravenous administration.

Conclusions:

• Particle-based therapies represent a promising approach to address the limitations of current treatments for MI and PAD.
• Further development of micro- and nano-particle delivery systems could significantly improve outcomes for patients with cardiovascular diseases.